Cai Lay Veterinary Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000MKV4
VND
15,300.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cai Lay Veterinary Pharmaceutical JSC stock-summary
stock-summary
Cai Lay Veterinary Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Cai Lay Veterinary Pharmaceutical Joint Stock Company is a Vietnam-based pharmaceutical company. It is engaged in the manufacture and trading of medicine and veterinary pharmaceutical products. The Company also manufactures and trades nutrition and feedstuff for animals. It is involved in the retail of drugs, medical equipment, cosmetics and sanitary products in specialized shops. In addition, the Company is involved in aquaculture and fishing activities, agricultural and forestry product processing, seafood trading, wood processing and the manufacture of wood furniture and other products for outdoor and indoor decoration purposes. It also trades breeding plants and fertilizers. The Company announces that AUSTFEED Vietnam Joint Stock Co has acquired 1,059,983 shares in the Company on February 22, 2013, raising its stake in the Company from 17.77% to 57.19%.
Company Coordinates stock-summary
Company Details
Khu pho 1, phuong 5, thi xa Cai Lay , TIEN GIANG None : None
stock-summary
Tel: 84 27 3382646284 07 33710769
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Luong Dao
Chairman of the Board of Management
Mr. Tuan Nguyen
Member of the Board of Management
Hoa Dao
Member of the Board of Management
Mr. Nam Le
Member of the Board of Management
Mr. Thoa Ngo
Member of the Board of Management
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
33,826 Million
(Quarterly Results - Jun 2025)
Net Profit:
2,269 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND 76,500 Million (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.21

stock-summary
Return on Equity

10.48%

stock-summary
Price to Book

0.79